Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2015 Jun;10(2):181-7.
doi: 10.1016/j.jsmc.2015.02.008. Epub 2015 Mar 23.

Melatonin Treatment in Children with Developmental Disabilities

Affiliations
Review

Melatonin Treatment in Children with Developmental Disabilities

A J Schwichtenberg et al. Sleep Med Clin. 2015 Jun.

Abstract

Melatonin is commonly recommended to treat sleep problems in children with developmental disabilities. However, few studies document the efficacy and safety of melatonin in these populations. This article reviews recent studies of melatonin efficacy in developmental disabilities. Overall, short treatment trials were associated with a significant decrease in sleep onset latency time for each of the disorders reviewed, with 1 notable exception-tuberous sclerosis. Reported side effects were uncommon and mild. Across disorders, additional research is needed to draw disability-specific conclusions. However, studies to date provide positive support for future trials that include larger groups of children with specific disabilities/syndromes.

Keywords: Angelman syndrome; Autism; Developmental disabilities; Melatonin; Sleep; Smith–Magenis syndrome.

PubMed Disclaimer

References

    1. Owens J, Rosen C, Mindell J, Kirchner H. Use of pharmacotherapy for insomnia in child psychiatry practice: A national survey. Sleep Medicine. 2010;11(7):692–700. - PubMed
    1. Guénolé F, Baleyte JM. Effects of melatonin should be studies separately in each neurodevelopmental disorder and with specific sleep diagnoses. Pediatric Neurology. 2012;46:60–61. - PubMed
    1. Braam W, Didden R, Smits M, Curfs L. Melatonin treatment in individuals with intellectual disability and chronic insomnia: a randomized placebo-controlled study. Journal of Intellectual Disability Research. 2008b;52:256–264. Doi: 10.1111/j.1365-27882007.01016.x. - PubMed
    1. Coppola G, Iervolino G, Mastrosimone M, La Torre G, Ruiu F, Pascotto A. Melatonin in wake-sleep disorders in children, adolescents, and young adults with mental retardation with or without epilepsy: a double-blind, cross-over, placebo-controlled trial. Brain and Development. 2004;26:373–376. Doi: 10.1016/S0387-7604(03)00197-9. - PubMed
    1. Dodge N, Wilson A G. Melatonin for treatment of sleep disorders in children with developmental disabilities. Journal Child Neurology. 2001;16:581–584. Doi: 101177/088307380101600808. - PubMed

Publication types

MeSH terms